Clin2
NCT04388124Possibly a fitRecruiting

Test drug to block endothelin for hard-to-control blood pressure

Resistant Hypertension

Treatments studied

Part of Heart & circulation clinical trials.

This Phase 2 trial tests whether blocking endothelin (using bosentan and related treatments) can improve blood pressure in people with resistant hypertension—high blood pressure that stays high despite multiple medicines. It may help if your blood pressure is still above target even with the right combination of therapy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
24 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 30 to 80 years old
  • Your blood pressure stays high despite 3 blood pressure medicines, including a water pill (diuretic), taken at the right dose
  • Your blood pressure is confirmed at home (average at least 135/85) or with 24-hour monitoring (average at least 130/80)
  • Your blood count is adequate (hemoglobin at least 12 g/dL)
  • You can safely use the study medicines based on pregnancy risk and other medical restrictions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07833098Not yet recruiting· Phase 2
A new medicine for hard-to-control high blood pressure

This study tests a new investigational medicine called VB19055 for people whose high blood pressure is not controlled even though they are already taking multiple blood pressure medications. The trial aims to see if this new drug can help lower blood pressure more effectively.

Baotou
NCT06282107Not yet recruiting
A new treatment for hard-to-control high blood pressure

This study tests a new treatment (called BiSAAE) for people whose blood pressure stays high despite taking several medicines. It aims to see if it can safely lower blood pressure better than current options.

NCT07081243Recruiting
A study on a procedure for hard-to-treat high blood pressure

This study looks at a procedure called renal denervation, which uses a device to calm overactive nerves in the kidneys that can drive high blood pressure. It is for people whose blood pressure stays high even with several medications, or who cannot tolerate blood pressure pills.

Shanghai, Shanghai Municipality
NCT07635914Not yet recruiting· Phase 3
Study of aprocitentan for resistant hypertension

This study tests a new medicine called aprocitentan (SYH9108) for people whose blood pressure stays high even when taking three or more blood pressure medicines. It aims to see if adding this medicine helps lower blood pressure more effectively.

NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07708441Not yet recruiting· Phase 2/Phase 3
Study of an experimental drug for hard-to-treat high blood pressure

This study tests an investigational drug called HRS-1780 for people with high blood pressure that is not well controlled or is resistant to treatment. The purpose is to see if it can lower blood pressure more effectively than current options.

Chongqing, Chongqing Municipality

Hear when a new Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.